Live Breaking News & Updates on Onxeo Sa Euronext

Stay updated with breaking news from Onxeo sa euronext. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Onxeo S.A.: Onxeo Changes Its Name and Becomes Valerio Therapeutics Following Approval by the Annual General Meeting of June 6, 2023

All the resolutions approved by the Board of Directors were adopted Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), ("Onxeo" or "the Company"), a clinical-stage biotechnology company ....

Mecklenburg Vorpommern , France General , Shefali Agarwal , Onxeo Sa Euronext , Nicolas Trebouta , Arthur Rouill , Robert Coleman , Nicolas Fossiez , Stefan Klotter , Company Group , Euronext Growth Paris , Annual General Meeting , Valerio Therapeutic , Chief Executive Officer , General Meeting , General Meetings , Stabile Ertr , Chart Profi Stefan Klotter , Blue Chips ,

Onxeo : changes its name and becomes Valerio Therapeutics following approval by the Annual General Meeting of June 6, 2023

All the resolutions approved by the Board of Directors were adopted

Paris , June 6, 2023 - 6:30 pm CEST - Onxeo S.A. , a clinical-stage biotechnology company specializing in. | June 6, 2023 ....

France General , Robert Coleman , Nicolas Trebouta , Onxeo Sa Euronext , Euronext Growth Paris , Annual General Meeting , Valerio Therapeutic , Onxeo Stock Exchange , Press Release , Pecializing Alonx Fr0010095596 ,

Onxeo Changes Its Name and Becomes Valerio Therapeutics Following Approval by the Annual General Mee

All the resolutions approved by the Board of Directors were adoptedPARIS (BUSINESS WIRE) Regulatory News:Onxeo S.A. (Euronext Growth Paris: ALONX), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR) and dr. ....

France General , Robert Coleman , Nicolas Trebouta , Nicolas Fossiez , Arthur Rouill , Shefali Agarwal , Onxeo Sa Euronext , Company Group , Regulatory News , Euronext Growth Paris , Annual General Meeting , Valerio Therapeutic , Chief Executive Officer , General Meeting , General Meetings ,

Onxeo S.A.: Onxeo: Combined General Meeting of June 6, 2023: Availability of Preparatory Documents and Participation & Voting Procedures

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR) and ....

France General , Onxeo Sa Euronext , Onis Onxeo , Arthur Rouill , Nicolas Fossiez , Gewinn Nur , Raymond Poincar , Renaissance Paris Nobel Tour Eiffel Hotel , Company Group , Regulatory News , Euronext Growth Paris , Combined General Meeting , General Meeting , General Meetings , Investor Relations ,

Onxeo S.A.: Onxeo: Publication of the 2022 Annual Financial Report

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), hereafter "Onxeo" or the "Company", a clinical-stage biotechnology company specializing in the development of innovative drugs targeting ....

France General , Onxeo Sa Euronext , Nicolas Fossiez , Arthur Rouill , Regulatory News , Euronext Growth Paris ,